3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
80
Neoplasm Metastasis
6
Neoplasms
3
Breast Neoplasms, Male
3
Arthralgia
2
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Skin Diseases
1
Prostatic Neoplasms
1
Post Menopausal Women With Early Breast Cancer
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Obesity
1
Metastatic Beast Cancer
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Lethal Congenital Contracture Syndrome 2
1
Invasive Early Breast Cancer
1
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
1
Fatigue
1
Estrogen-receptor Positive Invasive Metastatic Breast Cancer
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Advanced Breast Carcinoma
1
Interventions
selpercatinib
2
pralsetinib
2
sotorasib
1
pembrolizumab
1
patritumab
1
osimertinib
1
durvalumab
1
cobimetinib
1
alectinib
1
Tyrosine Kinase Inhibitors
1
Radiosurgery
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Dasatinib
1
Cisplatin
1
Carboplatin
1
Afatinib
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Respiratory Tract Diseases
×
exemestane
×
Clear all
No trials found.